Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 7/20 | 0.48 |
| ▸ | HTR2B | P41595 | 7/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | S100A4 | P26447 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.35 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7189579 | 0.87 | POLB (0.55) | HTR7HTR2BKMT2AMEN1LMNA | |
| SCHEMBL10965346 | 0.74 | HTR7 (0.62) | HTR7HTR2BKMT2AMEN1LMNA | |
| SCHEMBL4918205 | 0.72 | HTR7 (0.64) | HTR7HTR2BKMT2AMEN1LMNA | |
| SCHEMBL28485704 | 0.69 | MAPT (0.46) | KMT2ALMNAS100A4POLBPDK2 | |
| SCHEMBL6536414 | 0.68 | MAPT (0.52) | HTR7HTR2BKMT2ALMNAS100A4 | |
| SCHEMBL7741754 | 0.68 | S100A4 (0.85) | KMT2AMEN1LMNAS100A4POLB | |
| Bromide SCHEMBL17763401 | 0.65 | S100A4 (0.42) | HTR7HTR2BKMT2AMEN1LMNA | |
| SCHEMBL30037218 | 0.65 | KMT2A (0.45) | KMT2AMEN1S100A4GAAPOLB | |
| SCHEMBL28482431 | 0.65 | KMT2A (0.45) | KMT2AMEN1S100A4GAAPOLB | |
| SCHEMBL26121816 | 0.65 | HTR7 (0.58) | HTR7HTR2BKMT2AMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2548030-A2 | ENGINEERING CORRECTLY FOLDED ANTIBODIES USING INNER MEMBRANE DISPLAY OF TWIN-ARGININE TRANSLOCATION INTERMEDIATES | Cornell University (US) | 2013-01-23 | — | — | EP | disclosed |
| EP-2510088-A2 | ONCOLYTIC RHABDOVIRUS | Ottawa Hospital Research Institute (CA) | 2012-10-17 | — | — | EP | disclosed |
| WO-2011116276-A2 | ENGINEERING CORRECTLY FOLDED ANTIBODIES USING INNER MEMBRANE DISPLAY OF TWIN-ARGININE TRANSLOCATION INTERMEDIATES | DELISA MATTHEW (US) | 2011-09-22 | — | — | WO | disclosed |
| WO-2011070440-A2 | ONCOLYTIC RHABDOVIRUS | OTTAWA HOSPITAL RESEARCH INSTITUTE (CA) | 2011-06-16 | — | — | WO | disclosed |
| EP-2118124-A1 | IDENTIFICATION OF MULTIVALENT VIRAL ENVELOPE PROTEIN EPITOPES | Saint Louis University (US) | 2009-11-18 | — | — | EP | disclosed |
| EP-2087096-A2 | MODIFIED CYANOBACTERIA | Arizona Board Of Regents For And On Behalf Arizona State University (US) | 2009-08-12 | — | — | EP | disclosed |
| WO-2008130437-A2 | MODIFIED CYANOBACTERIA | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2008-10-30 | — | — | WO | disclosed |
| WO-2008089132-A2 | GENETIC SELECTION FOR PROTEIN FOLDING AND SOLUBILITY IN THE BACTERIAL PERIPLASM | CORNELL RESEARCH FOUNDATION, INC. (US) | 2008-07-24 | — | — | WO | disclosed |
| WO-2008083203-A1 | IDENTIFICATION OF MULTIVALENT VIRAL ENVELOPE PROTEIN EPITOPES | SAINT LOUIS UNIVERSITY (US) | 2008-07-10 | — | — | WO | disclosed |
| WO-2007101262-A2 | ATTENUATED FRANCISELLA BACTERIA | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-09-07 | — | — | WO | disclosed |
| EP-1651766-A2 | TARGETED CARRIER FUSIONS FOR DELIVERY OF CHEMOTHERAPEUTIC AGENTS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005014823-A2 | TARGETED CARRIER FUSIONS FOR DELIVERY OF CHEMOTHERAPEUTIC AGENTS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2005-02-17 | — | — | WO | disclosed |
| WO-2001027335-A1 | A NOVEL ADJUVANT | BAYLOR COLLEGE OF MEDICINE (US) | 2001-04-19 | — | — | WO | disclosed |